Scarica l'app Stockscreener
1.49
3.25%
-0.05
Pre-mercato:
1.48
-0.01
-0.67%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Opko Health Inc Borsa (OPK) Ultime notizie
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months - MarketBeat
OPKO Health at Wells Fargo conference: cash-rich pivot to therapeutics - Investing.com Canada
Bank of New York Mellon Corp Takes Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference - OPKO Health, Inc.
A healthcare conference will feature two OPKO executives on Sept. 10 - Stock Titan
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound? - Zacks Investment Research
OPKO Health, Inc. Revenue Breakdown – TRADEGATE:XCY - TradingView
OPK - Finviz
OPKO Health (NASDAQ:OPK) Sets New 1-Year HighHere's Why - MarketBeat
OPKO Health (NASDAQ:OPK) Trading Up 8.2%Here's Why - MarketBeat
BlackRock Inc. Takes Position in OPKO Health, Inc. $OPK - MarketBeat
Opko Health Inc (OPK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Income Statement - OPKO Health, Inc.
AWM Investment Company Inc. Makes New Investment in OPKO Health, Inc. $OPK - MarketBeat
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - TradingView
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Zacks Investment Research
OPK Raises $125 Million Against Royalties: What Investors Should Know - Eastern Progress
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? - TradingView
Zacks Research Has Positive View of OPKO Health Q3 Earnings - MarketBeat
OPKO (OPK) Latest Results Brief: EPS Prints Above Forecast in the Latest Reading; Shares After the Report: The Market Reaction Is MutedTrough Earnings Signal - Vinanet
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties - TradingView
Should OPKO Health’s Royalty-Backed US$125 Million Financing Shift Matter to OPKO Health (OPK) Investors? - Sahm
OPKO Health (OPK) Retreats to $1.38 as Support at $1.31 Comes into FocusMomentum Surge Alerts - vinanet.vn
OPKO Health (OPK) Raises $125 Million, Is The Upside Already Priced In? - Sahm
OPKO Health Raises $125 Million in Senior Secured Debt Financing - Minichart
OPKO Health (OPK) Slips to $1.38, Pressing Key Support at $1.31ATR Trailing Stop - vinanet.vn
OPKO Health Raises $125M Through Senior Secured Notes Backed by Mazdutide Royalties - Kalkine Media
OPKO Health Raises $125 Million in Additional Royalty-Backed Notes Under Amended HCR Agreement - TradingView
OPKO Health (NASDAQ:OPK) Trading Down 5.4%Here's What Happened - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Analysts - MarketBeat
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - OPKO Health, Inc.
OPKO Health, Inc. Expands Strategic Relationship with Healthcare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - marketscreener.com
OPKO Health secures $125m financing backed by mazdutide royalties - Investing.com Nigeria
OPKO Health Issues Additional $125 Million in Senior Notes Secured by Mazdutide Royalties - marketscreener.com
OPKO Health raises $125M in notes backed by mazdutide royalties - StreetInsider
OPKO Issues $125M Notes While Keeping Future Mazdutide Royalties - Stock Titan
OPKO Health, Inc. announced that it has received $375 million in funding from Healthcare Royalty Management, LLC - marketscreener.com
Opko Health, Inc. (OPK) Stock Analysis: Exploring A 214.75% Potential Upside - DirectorsTalk Interviews
Does OPKO Health’s Sharply Narrowed Q2 Loss Reset the Bull Case for OPKO Health (OPK)? - Sahm
OPKO Health (OPK) Advances 1.46% to $1.39, Approaching Key Resistance at $1.46Ichimoku Kumo Twist - vinanet.vn
OPKO Health Inc (OPK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Opko Health | SCHEDULE 13D: Others - Moomoo
OPKO Health, Inc. Discloses Investment in Cocrystal Pharma with 29.6% Stake - TradingView
OPKO Health: Mazdutide And MDX-2201 Could Change Everything (NASDAQ:OPK) - Seeking Alpha
OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
OPKO Health invests $5 million in Cocrystal Pharma By Investing.com - Investing.com South Africa
Weekly Recap: Q2 2026 financial results and MDX trial timelines - TradingView
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share - TradingView
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health - Stock Titan
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health - GlobeNewswire
OPKO Buys 5.47M Cocrystal Shares Ahead of Late-2026 Norovirus Data - Stock Titan
Opko Health Earnings Call Highlights Pipeline, Profit Pivot - The Globe and Mail
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):